Загрузка...
The First Case of Biological Therapy Discontinuation After a Complete Remission Induced by Maintenance Therapy With Adalimumab for Refractory Ulcerative Colitis
A 43-year-old woman, diagnosed with ulcerative colitis (UC) at age of 30, received outpatient treatment with corticosteroids. However, flare-up occurred, and adalimumab (ADA) treatment commenced in July 2009. A complete remission with mucosal healing was achieved by 32 weeks after initiation of ADA...
Сохранить в:
| Опубликовано в: : | J Clin Med Res |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elmer Press
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4245064/ https://ncbi.nlm.nih.gov/pubmed/25436030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr1991w |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|